Bayer predicts mid-single digit EBITDA rise in 2017

FRANKFURT, Feb 22 (Reuters) - Bayer, the German drugmaker that is buying U.S. seed maker Monsanto, said it expected a mid-single digit percentage increase in adjusted core earnings for 2017, helped by fast growing revenues from stroke prevention pill Xarelto.